Tokyo Tape
Sign in
← Medius Holdings

Half-year report · Q2

3154.TEDINET S100V7O6
Period2024-07-01 → 2024-12-31
Filed2025-02-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥142.7bn2024-07-01 → 2024-12-31Cons.Net sales
Revenue¥259.8bn2023-07-01 → 2024-06-30Cons.Net sales (5-year summary)
Revenue¥126.7bn2023-07-01 → 2023-12-31Cons.Net sales
Operating income¥751m2024-07-01 → 2024-12-31Cons.Operating income
Operating income¥681m2023-07-01 → 2023-12-31Cons.Operating income
Ordinary income¥983m2024-07-01 → 2024-12-31Cons.Ordinary income
Ordinary income¥1.8bn2023-07-01 → 2024-06-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥900m2023-07-01 → 2023-12-31Cons.Ordinary income
Profit before tax¥983m2024-07-01 → 2024-12-31Cons.Income before income taxes
Profit before tax¥895m2023-07-01 → 2023-12-31Cons.Income before income taxes
Net income (owners)¥407m2024-07-01 → 2024-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.1bn2023-07-01 → 2024-06-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥505m2023-07-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income¥407m2024-07-01 → 2024-12-31Cons.Profit loss
Net income¥505m2023-07-01 → 2023-12-31Cons.Profit loss
Total assets¥119.8bnat 2024-12-31Cons.Assets
Total assets¥114.8bnat 2024-06-30Cons.Assets
Total assets¥112.6bnat 2023-12-31Cons.Total assets (5-year summary)
Total liabilities¥99.8bnat 2024-12-31Cons.Liabilities
Total liabilities¥95.1bnat 2024-06-30Cons.Liabilities
Net assets / equity¥20.0bnat 2024-12-31Cons.Net assets
Net assets / equity¥19.7bnat 2024-06-30Cons.Net assets
Net assets / equity¥18.6bnat 2023-12-31Cons.Net assets (5-year summary)
Cash and deposits¥14.0bnat 2024-12-31Cons.Cash and deposits
Cash and deposits¥13.6bnat 2024-06-30Cons.Cash and deposits
Cash & equivalents¥14.0bnat 2024-12-31Cons.Cash and cash equivalents
Cash & equivalents¥13.5bnat 2024-06-30Cons.Cash and cash equivalents
Cash & equivalents¥14.0bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥10.3bnat 2023-06-30dCons.Cash and cash equivalents
Operating cash flow¥1.5bn2024-07-01 → 2024-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥1.9bn2023-07-01 → 2024-06-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.5bn2023-07-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥1.4bn2024-07-01 → 2024-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥2.7bn2023-07-01 → 2024-06-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.5bn2023-07-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Financing cash flow¥586m2024-07-01 → 2024-12-31Cons.Net cash provided by used in financing activities
Financing cash flow¥4.0bn2023-07-01 → 2024-06-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥6.7bn2023-07-01 → 2023-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥18.322024-07-01 → 2024-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥51.212023-07-01 → 2024-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥23.032023-07-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥18.322024-07-01 → 2024-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥512023-07-01 → 2024-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥22.932023-07-01 → 2023-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio16.7%at 2024-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio17.2%at 2024-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio16.5%at 2023-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 28
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-07-01 → 2024-12-31−¥9m
Reconciling Itemsreconcilingrevenue intersegment2024-07-01 → 2024-12-31−¥9m
Reconciling Itemsreconcilingsegment profit2024-07-01 → 2024-12-31−¥4.5bn
jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segmentrevenue2024-07-01 → 2024-12-31¥139.7bn
jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segmentrevenue external2024-07-01 → 2024-12-31¥139.7bn
jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segmentrevenue intersegment2024-07-01 → 2024-12-31¥9m
jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segmentsegment profit2024-07-01 → 2024-12-31¥5.0bn
jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segmentrevenue2024-07-01 → 2024-12-31¥3.0bn
jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segmentrevenue external2024-07-01 → 2024-12-31¥3.0bn
jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segmentsegment profit2024-07-01 → 2024-12-31¥250m
Total Of Reportable Segments And Otherssegment totalrevenue2024-07-01 → 2024-12-31¥142.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-07-01 → 2024-12-31¥142.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-07-01 → 2024-12-31¥9m
Total Of Reportable Segments And Otherssegment totalsegment profit2024-07-01 → 2024-12-31¥5.3bn
Reconciling Itemsreconcilingrevenue2023-07-01 → 2023-12-31−¥7m
Reconciling Itemsreconcilingrevenue intersegment2023-07-01 → 2023-12-31−¥7m
Reconciling Itemsreconcilingsegment profit2023-07-01 → 2023-12-31−¥4.2bn
jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segmentrevenue2023-07-01 → 2023-12-31¥123.8bn
jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segmentrevenue external2023-07-01 → 2023-12-31¥123.8bn
jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segmentrevenue intersegment2023-07-01 → 2023-12-31¥7m
jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segmentsegment profit2023-07-01 → 2023-12-31¥4.6bn
jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segmentrevenue2023-07-01 → 2023-12-31¥2.9bn
jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segmentrevenue external2023-07-01 → 2023-12-31¥2.9bn
jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segmentsegment profit2023-07-01 → 2023-12-31¥201m
Total Of Reportable Segments And Otherssegment totalrevenue2023-07-01 → 2023-12-31¥126.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-07-01 → 2023-12-31¥126.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-07-01 → 2023-12-31¥7m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-07-01 → 2023-12-31¥4.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 558
ItemContextValueUnit
Cash and cash equivalentsPrior2YearInstant10291467000JPY
Cash and cash equivalentsPrior1YearInstant13544776000JPY
Increase in cash and cash equivalents from newly consolidated subsidiary ccePrior1YTDDuration－JPY
Increase in cash and cash equivalents from newly consolidated subsidiary cceCurrentYTDDuration42959000JPY
Decrease in cash and cash equivalents resulting from change of fiscal term of subsidiaries cfPrior1YTDDuration－JPY
Decrease in cash and cash equivalents resulting from change of fiscal term of subsidiaries cfCurrentYTDDuration-304947000JPY
Cash and cash equivalentsPrior1QuarterInstant14008323000JPY
Cash and cash equivalentsCurrentQuarterInstant13984668000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E22995-000MedicalEquipmentSalesReportableSegmentsMember123824905000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E22995-000NursingCareAndWelfareReportableSegmentsMember2888150000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember126713055000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration126713055000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E22995-000MedicalEquipmentSalesReportableSegmentsMember6924000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E22995-000NursingCareAndWelfareReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember6924000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-6924000JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E22995-000MedicalEquipmentSalesReportableSegmentsMember123831829000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E22995-000NursingCareAndWelfareReportableSegmentsMember2888150000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember126719979000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-6924000JPY
Net salesPrior1YTDDuration126713055000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E22995-000MedicalEquipmentSalesReportableSegmentsMember4631679000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E22995-000NursingCareAndWelfareReportableSegmentsMember200521000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember4832200000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember-4151427000JPY
Operating incomePrior1YTDDuration680772000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E22995-000MedicalEquipmentSalesReportableSegmentsMember139709915000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E22995-000NursingCareAndWelfareReportableSegmentsMember2994904000JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember142704820000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration142704820000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E22995-000MedicalEquipmentSalesReportableSegmentsMember9040000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E22995-000NursingCareAndWelfareReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember9040000JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember-9040000JPY
Transactions with other segmentsCurrentYTDDuration－JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E22995-000MedicalEquipmentSalesReportableSegmentsMember139718956000JPY
Net salesCurrentYTDDuration_jpcrp040300-q2r_E22995-000NursingCareAndWelfareReportableSegmentsMember2994904000JPY
Net salesCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember142713861000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember-9040000JPY
Net salesCurrentYTDDuration142704820000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E22995-000MedicalEquipmentSalesReportableSegmentsMember5040007000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q2r_E22995-000NursingCareAndWelfareReportableSegmentsMember250414000JPY
Operating incomeCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember5290422000JPY
Operating incomeCurrentYTDDuration_ReconcilingItemsMember-4539403000JPY
Operating incomeCurrentYTDDuration751019000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-06-30pass rounding
balance sheet identityconsolidated 2024-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-06-30pass
statement vs summary · net assetsconsolidated 2024-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2024-07-01/2024-12-31pass
statement vs summary · operating cash flowconsolidated 2023-07-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2024-07-01/2024-12-31pass
statement vs summary · revenueconsolidated 2023-07-01/2023-12-31pass
statement vs summary · revenueconsolidated 2024-07-01/2024-12-31pass
statement vs summary · total assetsconsolidated 2024-06-30pass
statement vs summary · total assetsconsolidated 2024-12-31pass